[PERSON]
Michael Davis
Featured in 1 tracked story · first seen
Situations
Merck Lipfendra oral PCSK9 approval
4 clusters · 51 sources · last updated
Latest: FDA approves Merck's oral PCSK9 inhibitor Lipfendra to lower LDL cholesterol
The U.S. Food and Drug Administration has confirmed approval of Merck’s Lipfendra (enlicitil‑de), the first once‑daily oral tablet that inhibits the PCSK9 protein. Clinical trials in more than 3,200 adults with primary h